ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
Authors
Keywords
Sialic acid, Cisplatin, Ovarian cancer, Apoptosis, Glycosylation
Journal
Journal of Ovarian Research
Volume 6, Issue 1, Pages 25
Publisher
Springer Nature
Online
2013-04-11
DOI
10.1186/1757-2215-6-25
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines
- (2013) A. F. Swindall et al. CANCER RESEARCH
- Regulation of the metastatic cell phenotype by sialylated glycans
- (2012) Matthew J. Schultz et al. CANCER AND METASTASIS REVIEWS
- Glycosylation, galectins and cellular signaling
- (2011) Cecile Boscher et al. CURRENT OPINION IN CELL BIOLOGY
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells
- (2011) Amanda F. Swindall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ST6Gal-I Regulates Macrophage Apoptosis via α2-6 Sialylation of the TNFR1 Death Receptor
- (2011) Zhongyu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
- (2010) K. L. Chock et al. CANCER RESEARCH
- Combination versus sequential cytotoxic chemotherapy in recurrent ovarian cancer: Time for an evidence-based comparison
- (2010) Maurie Markman GYNECOLOGIC ONCOLOGY
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
- (2009) Giovanni Luca Beretta et al. BIOCHEMICAL PHARMACOLOGY
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
- (2009) B. G. Blair et al. CLINICAL CANCER RESEARCH
- T-cell growth, cell surface organization, and the galectin-glycoprotein lattice
- (2009) Ani Grigorian et al. IMMUNOLOGICAL REVIEWS
- N- andO-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death
- (2009) Lesley A. Earl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quality control of human ABCG2 protein in the endoplasmic reticulum: Ubiquitination and proteasomal degradation
- (2008) Kanako Wakabayashi-Nakao et al. ADVANCED DRUG DELIVERY REVIEWS
- Galectin–glycan lattices regulate cell-surface glycoprotein organization and signalling: Table 1
- (2008) Omai B. Garner et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system
- (2008) Hiroaki Nakagawa et al. CANCER LETTERS
- Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms
- (2008) Faheem M. Shaikh et al. EXPERIMENTAL CELL RESEARCH
- Sialylation of 1 Integrins Blocks Cell Adhesion to Galectin-3 and Protects Cells against Galectin-3-induced Apoptosis
- (2008) Y. Zhuo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein Sialylation by Sialyltransferase Involves Radiation Resistance
- (2008) M. Lee et al. MOLECULAR CANCER RESEARCH
- ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function
- (2008) Daniel R Christie et al. Journal of Ovarian Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now